動静脈奇形の世界市場レポート 2025年

動静脈奇形市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）7.4％で41億3,000万米ドルに成長します。予測期間中に予測される成長は、遺伝子治療の利用増加、先端医療技術に対する需要の高まり、質の高いヘルスケアに対するニーズの高まり、神経系薬剤の消費増加、高齢化人口の拡大などに起因しています。この期間に予想される主要動向には、治療選択肢の進歩、医療技術の革新、マイクロサージャリー技術の進歩、カテーテル技術の発展、低侵襲外科手術の改善などがあります。

低侵襲手術に対する需要の高まりが、動静脈奇形（AVMs）市場の拡大を牽引すると予想されます。低侵襲手技は、小さな切開やカテーテルベースの手技を用いた外科的または治療的介入を含み、外傷を最小限に抑え、回復時間を短縮し、合併症のリスクを低下させています。これらの手技は、切開創が小さいほど組織損傷が少なく治癒時間が短縮されるため、回復が早くなることから人気が高まっています。そのため、従来型開腹手術に比べ、患者はより早く日常生活に戻ることができ、患者とヘルスケア提供者の双方にとって好ましい選択となっています。動静脈奇形は、血管内塞栓術のような先進的技術を用いて治療され、カテーテルや画像誘導手技を用いることで、開腹手術を必要とせずに異常な血流を減少させることができます。このアプローチは、より低いリスク、より早い回復、患者の転帰の改善につながります。例えば、2023年9月、米国形成外科学会（American Society of Plastic Surgeons）は、2023年に2,544万2,640件の美容的低侵襲手術が行われ、2022年の2,367万2,269件から7％増加したと報告しました。この成長は、低侵襲治療への嗜好の高まりを浮き彫りにし、AVMs市場の成長に寄与しています。

また、バイオテクノロジーへの投資の増加も、動静脈奇形市場の成長を促進すると期待されています。バイオテクノロジーには、ヘルスケア関連の製品や技術を開発するために生物学的プロセス、生物、システムを利用することが含まれます。バイオテクノロジーへの投資は、精密な遺伝子改変や医療革新を可能にするCRISPRなどの遺伝子編集技術の躍進により急増しています。動静脈奇形は、医療イメージング、遺伝子治療、低侵襲治療の改善によってバイオテクノロジーに貢献し、標的ドラッグデリバリー、血管修復用生体材料、AI支援診断などのバイオテクノロジーによるソリューションの開発につながります。2024年8月、バイオインダストリー協会（BIA）は、英国のライフサイエンス・バイオテクノロジー部門が2024年第1～2四半期に25億5,000万米ドルの投資を確保し、2023年に調達した23億2,000万米ドルを上回ったと報告しました。このバイオテクノロジー投資の増加がAVM市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の動静脈奇形PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の動静脈奇形市場：成長率分析
• 世界の動静脈奇形市場の実績：規模と成長、2019～2024年
• 世界の動静脈奇形市場の予測：規模と成長、2024～2029年、2034年
• 世界の動静脈奇形総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の動静脈奇形市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 真性動静脈奇形
• オカルトまたはクリプティック
• 海綿状奇形
• 静脈奇形
• 血管腫
• 硬膜瘻
• その他のタイプ
• 世界の動静脈奇形市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 身体検査
• 脳スキャン
• その他
• 世界の動静脈奇形市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 血管内塞栓術
• 脳神経外科
• 世界の動静脈奇形市場：年齢層別、実績と予測、2019～2024年、2024～2029年、2034年
• 成人患者
• 小児患者
• 世界の動静脈奇形市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院とクリニック
• ラボ
• その他
• 世界の動静脈奇形市場、真性動静脈奇形のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 軟膜動静脈奇形
• 脊髄動静脈奇形
• 脳動静脈奇形
• 四肢動静脈奇形
• 内臓動静脈奇形
• 世界の動静脈奇形市場、オカルトまたはクリプティックのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 微小動静脈奇形
• 潜在脳動静脈奇形
• 無症候性脳動静脈奇形
• 深部動静脈奇形
• 小規模AVM
• 世界の動静脈奇形市場、海綿状奇形のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 脳海綿状奇形（CCM）
• 脊椎海綿状奇形
• 家族性海綿状奇形
• 孤立性海綿状奇形
• 多発性海綿状奇形
• 世界の動静脈奇形市場、静脈奇形のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 表在静脈奇形
• 深部静脈奇形
• 混合静脈奇形
• 症候群性静脈奇形
• 青色ゴム疱母斑症候群
• 世界の動静脈奇形市場、血管腫のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 乳児血管腫
• 毛細血管腫
• 小葉性毛細血管腫
• 海綿状血管腫
• 複合血管腫
• 世界の動静脈奇形市場、硬膜瘻のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 頭蓋硬膜動静脈瘻（dAVF）
• 脊髄硬膜動静脈瘻
• 直接硬膜動静脈瘻
• 間接硬膜動静脈瘻
• 高流量硬膜瘻
• 世界の動静脈奇形市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• リンパ管奇形
• 混合血管奇形
• 動静脈瘤
• 遺伝性出血性毛細血管拡大症（HHT）関連動静脈奇形
• まれな先天性動静脈奇形

第7章 地域別・国別分析

• 世界の動静脈奇形市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の動静脈奇形市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動静脈奇形市場：競合情勢
• 動静脈奇形市場：企業プロファイル
  • Johnson And Johnson Services Inc.
  • Siemens AG
  • Medtronic Plc
  • Koninklijke Philips N V
  • Stryker Corporation

第31章 その他の大手企業と革新的企業

• GE Healthcare Technologies Inc
• Cedars-Sinai
• Penn Medicine
• Terumo Corporation
• Eisai Co Ltd
• Cook Medical LLC
• Elekta AB
• Merit Medical Systems Inc.
• Penumbra Inc.
• Max Healthcare
• RWJBarnabas Health
• Balt LLC
• Booking Health GmbH
• Duke University Health System
• Shape Memory Medical Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 動静脈奇形市場、2029年：新たな機会を提供する国
• 動静脈奇形市場、2029年：新たな機会を提供するセグメント
• 動静脈奇形市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Arteriovenous malformations are abnormal tangles of blood vessels that form direct connections between arteries and veins, bypassing the normal capillary system. This disruption affects normal blood flow and oxygen circulation, potentially leading to complications. Early diagnosis and appropriate treatment are essential for managing symptoms and reducing the risk of severe complications.

The primary types of arteriovenous malformations include true arteriovenous malformation, occult or cryptic malformations, cavernous malformations, venous malformations, hemangiomas, dural fistulas, and others. True arteriovenous malformation is a congenital vascular anomaly characterized by a direct connection between arteries and veins, bypassing the capillary system. Diagnosis methods include physical examinations, brain scans, and other imaging techniques. Treatment options consist of endovascular embolization and neurosurgery, catering to different age groups such as adult and pediatric patients. These treatments are utilized across various end-users, including hospitals and clinics, research laboratories, and others.

The arteriovenous malformations market research report is one of a series of new reports from The Business Research Company that provides arteriovenous malformations market statistics, including arteriovenous malformations industry global market size, regional shares, competitors with a arteriovenous malformations market share, detailed arteriovenous malformations market segments, market trends and opportunities, and any further data you may need to thrive in the arteriovenous malformations industry. These arteriovenous malformations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The arteriovenous malformations market size has grown strongly in recent years. It will grow from $2.88 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to the rising prevalence of arteriovenous malformations, the increasing occurrence of neurological and brain disorders, the growing need for improved treatments for rare diseases, enhanced government support for research and development, and the expansion of the business sector.

The arteriovenous malformations market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The projected growth during the forecast period can be attributed to the increasing use of gene therapy, the rising demand for advanced medical technology, the growing need for quality healthcare, the increasing consumption of neurological drugs, and the expansion of the aging population. Key trends expected during this period include advancements in treatment options, innovations in medical technology, progress in microsurgical techniques, developments in catheter technology, and improvements in minimally invasive surgical procedures.

The growing demand for minimally invasive procedures is expected to drive the expansion of the arteriovenous malformations (AVMs) market. Minimally invasive procedures involve surgical or therapeutic interventions that use small incisions or catheter-based techniques to minimize trauma, reduce recovery time, and lower the risk of complications. These procedures are increasingly popular because they enable faster recovery, as smaller incisions cause less tissue damage and shorten healing times. This allows patients to return to their daily routines more quickly compared to traditional open surgeries, making them a preferred choice for both patients and healthcare providers. Arteriovenous malformations are treated using advanced techniques such as endovascular embolization, where catheters and image-guided procedures are employed to reduce abnormal blood flow without the need for open surgery. This approach leads to lower risks, quicker recovery, and improved patient outcomes. For example, in September 2023, the American Society of Plastic Surgeons reported that 25,442,640 cosmetic minimally invasive procedures were performed in 2023, reflecting a 7% increase from the 23,672,269 procedures in 2022. This growth highlights the rising preference for minimally invasive treatments and contributes to the growth of the AVMs market.

Increasing investment in biotechnology is also expected to drive the growth of the arteriovenous malformations market. Biotechnology involves the use of biological processes, organisms, or systems to develop healthcare-related products and technologies. Investment in biotechnology has surged due to breakthroughs in gene editing technologies such as CRISPR, which enable precise genetic modifications and medical innovations. Arteriovenous malformations contribute to biotechnology by improving medical imaging, gene therapy, and minimally invasive treatments, leading to the development of biotechnology-based solutions such as targeted drug delivery, biomaterials for vascular repair, and AI-assisted diagnostics. In August 2024, The BioIndustry Association (BIA) reported that the UK's life sciences and biotechnology sector secured $2.55 billion in investment during the first two quarters of 2024, surpassing the $2.32 billion raised in 2023. This increase in biotechnology investment is helping to drive the growth of the AVMs market.

Companies in the arteriovenous malformations market are also focusing on technological advancements, such as liquid embolic system procedural sets, to enhance treatment procedures and improve patient outcomes. A liquid embolic system procedural set is a pre-assembled, sterilized kit that contains the essential components needed to deliver liquid embolic agents to treat vascular abnormalities such as AVMs. For instance, in March 2024, CERENOVUS Inc., a US-based neurovascular care company under Johnson and Johnson MedTech, introduced the TRUFILL n-BCA liquid embolic system procedural set. This new set includes two configurations and all necessary accessories for preparing and delivering the n-BCA liquid embolic system in a single sterilized package, making procedure preparation more efficient for treating cerebral AVMs.

Major players in the arteriovenous malformations market are Johnson And Johnson Services Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N V, Stryker Corporation, GE Healthcare Technologies Inc, Cedars-Sinai, Penn Medicine, Terumo Corporation, Eisai Co Ltd, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc., Penumbra Inc., Max Healthcare, RWJBarnabas Health, Balt LLC, Booking Health GmbH, Duke University Health System, Shape Memory Medical Inc.

North America was the largest region in the arteriovenous malformations market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arteriovenous malformations report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the arteriovenous malformations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arteriovenous malformations market consists of revenues earned by entities by providing services such as minimally invasive embolization, post-procedure rehabilitation, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The arteriovenous malformations market also includes sales of embolization devices, neurovascular catheters, liquid embolic agents, microsurgical instruments, and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arteriovenous Malformations Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arteriovenous malformations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for arteriovenous malformations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arteriovenous malformations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: True Arteriovenous Malformation; Occult Or Cryptic; Cavernous Malformations; Venous Malformation; Hemangioma; Dural Fistula; Other Types
• 2) By Diagnosis: Physical examination; Brain Scans; Other Diagnosis
• 3) By Treatment: Endovascular Embolization; Neurosurgery
• 4) By Age Group: Adult Patients; Pediatric Patients
• 5) By End-User: Hospitals And Clinics; Research laboratories; Other End-Users
• Sub Segments:
• 1) By True Arteriovenous Malformation Type: Pial AVMs; Spinal AVMs; Brain AVMs; Extremity AVMs; Visceral AVMs
• 2) By Occult or Cryptic Type: Micro-AVMs; Hidden AVMs; Asymptomatic AVMs; Deep-Seated AVMs; Small-Scale AVMs
• 3) By Cavernous Malformations Type: Cerebral Cavernous Malformations (CCMs); Spinal Cavernous Malformations; Familial Cavernous Malformations; Solitary Cavernous Malformations; Multiple Cavernous Malformations
• 4) By Venous Malformation Type: Superficial Venous Malformations; Deep Venous Malformations; Mixed Venous Malformations; Syndromic Venous Malformations; Blue Rubber Bleb Nevus Syndrome
• 5) By Hemangioma Type: Infantile Hemangiomas; Capillary Hemangiomas; Lobular Capillary Hemangiomas; Cavernous Hemangiomas; Compound Hemangiomas
• 6) By Dural Fistula Type: Cranial Dural Arteriovenous Fistula (dAVF); Spinal Dural Arteriovenous Fistula; Direct Dural AV Fistula; Indirect Dural AV Fistula; High-Flow Dural Fistula
• 7) By Other Types: Lymphatic Malformations; Mixed Vascular Malformations; Arteriovenous Aneurysms; Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs; Rare Congenital AVMs
• Companies Mentioned: Johnson And Johnson Services Inc.; Siemens AG; Medtronic Plc; Koninklijke Philips N V; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Arteriovenous Malformations Market Characteristics

3. Arteriovenous Malformations Market Trends And Strategies

4. Arteriovenous Malformations Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Arteriovenous Malformations Growth Analysis And Strategic Analysis Framework

• 5.1. Global Arteriovenous Malformations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Arteriovenous Malformations Market Growth Rate Analysis
• 5.4. Global Arteriovenous Malformations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Arteriovenous Malformations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Arteriovenous Malformations Total Addressable Market (TAM)

6. Arteriovenous Malformations Market Segmentation

• 6.1. Global Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• True Arteriovenous Malformation
• Occult Or Cryptic
• Cavernous Malformations
• Venous Malformation
• Hemangioma
• Dural Fistula
• Other Types
• 6.2. Global Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical examination
• Brain Scans
• Other Diagnosis
• 6.3. Global Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endovascular Embolization
• Neurosurgery
• 6.4. Global Arteriovenous Malformations Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult Patients
• Pediatric Patients
• 6.5. Global Arteriovenous Malformations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research laboratories
• Other End-Users
• 6.6. Global Arteriovenous Malformations Market, Sub-Segmentation Of True Arteriovenous Malformation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pial AVMs
• Spinal AVMs
• Brain AVMs
• Extremity AVMs
• Visceral AVMs
• 6.7. Global Arteriovenous Malformations Market, Sub-Segmentation Of Occult or Cryptic Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Micro-AVMs
• Hidden AVMs
• Asymptomatic AVMs
• Deep-Seated AVMs
• Small-Scale AVMs
• 6.8. Global Arteriovenous Malformations Market, Sub-Segmentation Of Cavernous Malformations Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cerebral Cavernous Malformations (CCMs)
• Spinal Cavernous Malformations
• Familial Cavernous Malformations
• Solitary Cavernous Malformations
• Multiple Cavernous Malformations
• 6.9. Global Arteriovenous Malformations Market, Sub-Segmentation Of Venous Malformation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Superficial Venous Malformations
• Deep Venous Malformations
• Mixed Venous Malformations
• Syndromic Venous Malformations
• Blue Rubber Bleb Nevus Syndrome
• 6.10. Global Arteriovenous Malformations Market, Sub-Segmentation Of Hemangioma Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infantile Hemangiomas
• Capillary Hemangiomas
• Lobular Capillary Hemangiomas
• Cavernous Hemangiomas
• Compound Hemangiomas
• 6.11. Global Arteriovenous Malformations Market, Sub-Segmentation Of Dural Fistula Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cranial Dural Arteriovenous Fistula (dAVF)
• Spinal Dural Arteriovenous Fistula
• Direct Dural AV Fistula
• Indirect Dural AV Fistula
• High-Flow Dural Fistula
• 6.12. Global Arteriovenous Malformations Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lymphatic Malformations
• Mixed Vascular Malformations
• Arteriovenous Aneurysms
• Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs
• Rare Congenital AVMs

7. Arteriovenous Malformations Market Regional And Country Analysis

• 7.1. Global Arteriovenous Malformations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Arteriovenous Malformations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Arteriovenous Malformations Market

• 8.1. Asia-Pacific Arteriovenous Malformations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Arteriovenous Malformations Market

• 9.1. China Arteriovenous Malformations Market Overview
• 9.2. China Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Arteriovenous Malformations Market

• 10.1. India Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Arteriovenous Malformations Market

• 11.1. Japan Arteriovenous Malformations Market Overview
• 11.2. Japan Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Arteriovenous Malformations Market

• 12.1. Australia Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Arteriovenous Malformations Market

• 13.1. Indonesia Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Arteriovenous Malformations Market

• 14.1. South Korea Arteriovenous Malformations Market Overview
• 14.2. South Korea Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Arteriovenous Malformations Market

• 15.1. Western Europe Arteriovenous Malformations Market Overview
• 15.2. Western Europe Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Arteriovenous Malformations Market

• 16.1. UK Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Arteriovenous Malformations Market

• 17.1. Germany Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Arteriovenous Malformations Market

• 18.1. France Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Arteriovenous Malformations Market

• 19.1. Italy Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Arteriovenous Malformations Market

• 20.1. Spain Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Arteriovenous Malformations Market

• 21.1. Eastern Europe Arteriovenous Malformations Market Overview
• 21.2. Eastern Europe Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Arteriovenous Malformations Market

• 22.1. Russia Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Arteriovenous Malformations Market

• 23.1. North America Arteriovenous Malformations Market Overview
• 23.2. North America Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Arteriovenous Malformations Market

• 24.1. USA Arteriovenous Malformations Market Overview
• 24.2. USA Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Arteriovenous Malformations Market

• 25.1. Canada Arteriovenous Malformations Market Overview
• 25.2. Canada Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Arteriovenous Malformations Market

• 26.1. South America Arteriovenous Malformations Market Overview
• 26.2. South America Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Arteriovenous Malformations Market

• 27.1. Brazil Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Arteriovenous Malformations Market

• 28.1. Middle East Arteriovenous Malformations Market Overview
• 28.2. Middle East Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Arteriovenous Malformations Market

• 29.1. Africa Arteriovenous Malformations Market Overview
• 29.2. Africa Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Arteriovenous Malformations Market Competitive Landscape And Company Profiles

• 30.1. Arteriovenous Malformations Market Competitive Landscape
• 30.2. Arteriovenous Malformations Market Company Profiles
  • 30.2.1. Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N V Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Arteriovenous Malformations Market Other Major And Innovative Companies

• 31.1. GE Healthcare Technologies Inc
• 31.2. Cedars-Sinai
• 31.3. Penn Medicine
• 31.4. Terumo Corporation
• 31.5. Eisai Co Ltd
• 31.6. Cook Medical LLC
• 31.7. Elekta AB
• 31.8. Merit Medical Systems Inc.
• 31.9. Penumbra Inc.
• 31.10. Max Healthcare
• 31.11. RWJBarnabas Health
• 31.12. Balt LLC
• 31.13. Booking Health GmbH
• 31.14. Duke University Health System
• 31.15. Shape Memory Medical Inc.

32. Global Arteriovenous Malformations Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Arteriovenous Malformations Market

34. Recent Developments In The Arteriovenous Malformations Market

35. Arteriovenous Malformations Market High Potential Countries, Segments and Strategies

• 35.1 Arteriovenous Malformations Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Arteriovenous Malformations Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Arteriovenous Malformations Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer